- +1 551 333 1547
- +44 2070 979277
- live:skype_chat
Speak with Analyst
View Synopsis & Table of Content
Hemophilia Treatment Comprehensive Study by Type (Replacement therapy, ITI therapy, Gene therapy), Disease Type (Hemophilia A, Hemophilia B, Hemophilia C), Treatment (Recombinant Coagulation Factor, Plasma-Derived Coagulation Factor, Desmopressin, Antifibrinolytic Agents), End-users (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2030
Hemophilia Treatment Market by Key Segments | Forecast Years: 2024- 2030 | CAGR:6.3%
{reportSlug=global-hemophilia-treatment-market, reportId=58384, mktKeyword=Hemophilia Treatment, cagr=6.30, publishDate=Mar 2024, priceOption2=6800, reportTitle=Hemophilia Treatment Comprehensive Study by Type (Replacement therapy, ITI therapy, Gene therapy), Disease Type (Hemophilia A, Hemophilia B, Hemophilia C), Treatment (Recombinant Coagulation Factor, Plasma-Derived Coagulation Factor, Desmopressin, Antifibrinolytic Agents), End-users (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=200, priceOption1=3650, forecastYr=2030, noOfPages=205, reportKey=58072, breadcrum=Global Hemophilia Treatment}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Mar 2024
205 Pages
66 Tables
Base Year: 2023
Coverage: 15+ Companies; 18
Countries
